Researchers evaluated health records from a large US health system to determine whether common rheumatologic conditions and immunomodulatory drugs were associated with certain COVID-19 outcomes.
Researchers investigated the risk for infection between leflunomide vs TNFi and tacrolimus vs TFNi among patients with rheumatoid arthritis treated with concomitant methotrexate.
Researchers assessed the severity of COVID-19 and thrombotic complications after COVID-19 vaccination in patients with high-risk antiphospholipid syndrome.
Researchers determined the role of infection with Epstein-Barr virus on risk of developing rheumatoid arthritis.
At an ACR Convergence 2021 session, John Aucott, MD, and Sheila Arvikar, MD, discussed the various aspects of Lyme arthritis, including incidence, prevalence, symptoms, and treatments, and other tick-borne illnesses, to inform rheumatologists in practice.
Researchers evaluated the link between hydroxychloroquine use and corrected QT length in patients with SLE and RA without cardiovascular disease.
Researchers investigated the association between rituximab and severe COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases.
The American College of Rheumatology developed clinical guidance for the use of COVID-19 vaccines in patients with rheumatic and musculoskeletal diseases.
